Form 990 for tax year 2023
Filed by VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC.
Totals
- Total revenue
- $10,946,946
- Total expenses
- $11,357,497
- Contributions and grants received
- $5,836,992
- Grants paid
- $9,242,529
- Program service revenue
- $0
- Investment income
- $4,768,070
- Other revenue
- $341,884
- Total assets, end of year
- $133,873,238
- Total liabilities, end of year
- $1,501,991
- Net assets or fund balances, end of year
- $132,371,247
- Program services expenses (Part IX)
- $9,242,529
- Management and general expenses
- $673,070
- Fundraising expenses
- $1,441,898
- Program service expenses (Part III)
- $9,242,529
Program services were 81.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$6,500
-
1c · Fundraising events
$336,750
-
1d · Related organizations
$3,810,000
-
1f · All other contributions, gifts and grants
$1,683,742
-
1g · Noncash contributions included above
$300,356
-
3 · Investment income
total $3,259,985 · unrelated business -$20,792 · excluded $3,280,777
-
5 · Royalties
total $377,678 · excluded $377,678
-
7a · Gross sales of assets other than inventory
securities $10,506,170
-
7b · Less cost or other basis and sales expenses
securities $8,998,085
-
7c · Gain or loss
securities $1,508,085
-
7d · Net gain or loss
total $1,508,085 · unrelated business $24,632 · excluded $1,483,453
-
8a · Fundraising events: gross income
$63,798
-
8a · Fundraising events: contributions included on line 1c
$336,750
-
8b · Fundraising events: direct expenses
$99,592
-
8c · Net income from fundraising events
total -$35,794 · excluded -$35,794
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $9,242,529 · program services $9,242,529
-
5 · Compensation of officers, directors and key employees
total $262,013 · management and general $34,154 · fundraising $227,859
-
7 · Other salaries and wages
total $566,710 · management and general $188,565 · fundraising $378,145
-
8 · Pension plan contributions
total $29,780 · management and general $11,473 · fundraising $18,307
-
9 · Other employee benefits
total $101,044 · management and general $35,125 · fundraising $65,919
-
10 · Payroll taxes
total $56,433 · management and general $16,190 · fundraising $40,243
-
11b · Fees: legal
total $135,441 · management and general $135,441
-
11c · Fees: accounting
total $4,400 · management and general $4,400
-
11e · Fees: professional fundraising services
total $441,440 · fundraising $441,440
-
11f · Fees: investment management
total $152,186 · management and general $152,186
-
11g · Fees: other
total $151,419 · management and general $77 · fundraising $151,342
-
12 · Advertising and promotion
total $56,225 · fundraising $56,225
-
13 · Office expenses
total $748 · fundraising $748
-
14 · Information technology
total $32,419 · management and general $3,250 · fundraising $29,169
-
15 · Royalties
total $63,879 · management and general $63,879
-
16 · Occupancy
total $1,100 · fundraising $1,100
-
17 · Travel
total $5,904 · management and general $240 · fundraising $5,664
-
19 · Conferences, conventions and meetings
total $13,743 · management and general $302 · fundraising $13,441
-
22 · Depreciation, depletion and amortization
total $4,145 · fundraising $4,145
-
24a · Other expenses: UBI TAXES
total $25,781 · management and general $25,781
-
24b · Other expenses: EQUIPMENT LEASE & MAINT
total $7,277 · management and general $474 · fundraising $6,803
-
24c · Other expenses: MEDICAL LAB SUPPLIES
total $1,653 · management and general $1,653
-
24d · Other expenses: DUES & MEMBERSHIPS
total $1,529 · management and general $595 · fundraising $934
-
24e · All other expenses
total -$301 · management and general -$715 · fundraising $414
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $0 · end of year $0
-
2 · Savings and temporary cash investments
beginning of year $9,180,588 · end of year $4,753,757
-
3 · Pledges and grants receivable
beginning of year $1,633,243 · end of year $1,554,665
-
4 · Accounts receivable
beginning of year $159,526 · end of year $97,087
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $0 · end of year $0
-
10a · Land, buildings and equipment: cost or other basis
$54,657
-
10b · Land, buildings and equipment: accumulated depreciation
$50,791
-
10c · Land, buildings and equipment, net
beginning of year $8,011 · end of year $3,866
-
11 · Investments: publicly traded securities
beginning of year $73,994,112 · end of year $90,599,806
-
12 · Investments: other securities
beginning of year $38,487,580 · end of year $36,864,057
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $0 · end of year $0
-
17 · Accounts payable and accrued expenses
beginning of year $1,144,589 · end of year $1,501,991
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $0 · end of year $0
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $0 · end of year $0
-
27 · Net assets without donor restrictions
beginning of year $114,524,341 · end of year $123,216,504
-
28 · Net assets with donor restrictions
beginning of year $7,794,130 · end of year $9,154,743
Mission and programs · 2023
Mission
(SEE SCHEDULE O)
Activities or mission (Part I)
VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION ADVANCES LIFE-SAVING BASIC AND CLINICAL BLOOD RESEARCH.
-
VBRIF SUPPORTS BLOOD RESEARCH RELATED TO TRANSFUSION, TRANSLATIONAL, CLINICAL AND TRANSPLANT MEDICINE.
Expenses $9,185,204 · Grants $9,185,204
-
VBRIF SUPPORTS THE EFFORTS OF ITS SUPPORTED ORGANIZATIONS, WHICH FURTHER THE IMPORTANT CAUSES OF BLOOD AND ORGAN DONATIONS AND RESEARCH.
Expenses $57,325 · Grants $57,325
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Chris MiskelCHRIS MISKEL
PRESIDENT & CEO
- Total calculated
- $1,480,476
- From this org
- $0
- From related orgs
- $1,425,101
- Other
- $55,375
- Hours/week
- 1 + 54 related
Schedule J breakdown matched by us
- Base
- $0 + $767,497 related
- Bonus
- $0 + $633,934 related
- Other
- $0 + $23,670 related
- Deferred
- $0 + $22,500 related
- Nontaxable benefits
- $0 + $32,875 related
- Filer's total
- $0 + $1,480,476 related
-
Julia SyburgJULIA SYBURG
CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Dixon Benz IIDIXON BENZ II
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Andy Anderson MDANDY ANDERSON MD
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Guy CraneGUY CRANE
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
Sam BradtSAM BRADT
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Louise CrowleyLOUISE CROWLEY
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
William CrowleyWILLIAM CROWLEY
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Jason DvorakJASON DVORAK
BOARD MEMBER - AS OF 9/2023
- Total calculated
- $0
- Hours/week
- 1
-
Fred GeilfussFRED GEILFUSS
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Emery HarlanEMERY HARLAN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Thomas Hauske JrTHOMAS HAUSKE JR
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Kathy KleinKATHY KLEIN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Robert H ManegoldROBERT H MANEGOLD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 5 related
-
Abhishek PulakantiABHISHEK PULAKANTI
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
John R Raymond Sr MDJOHN R RAYMOND SR MD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Johan SegerdahlJOHAN SEGERDAHL
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Suzy StemperSUZY STEMPER
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Michael H WhiteMICHAEL H WHITE
BOARD MEMBER - THRU 6/2023
- Total calculated
- $0
- Hours/week
- 1
-
Bart ReuterBART REUTER
EVP & GENERAL COUNSEL
- Total calculated
- $785,165
- From this org
- $0
- From related orgs
- $720,940
- Other
- $64,225
- Hours/week
- 1 + 54 related
Schedule J breakdown matched by us
- Base
- $0 + $410,935 related
- Bonus
- $0 + $284,861 related
- Other
- $0 + $25,144 related
- Deferred
- $0 + $23,100 related
- Nontaxable benefits
- $0 + $41,125 related
- Filer's total
- $0 + $785,165 related
-
Anthony WatkinsANTHONY WATKINS
EVP & CHIEF FINANCIAL OFFICER
- Total calculated
- $781,954
- From this org
- $0
- From related orgs
- $741,823
- Other
- $40,131
- Hours/week
- 1 + 54 related
Schedule J breakdown matched by us
- Base
- $0 + $429,713 related
- Bonus
- $0 + $282,211 related
- Other
- $0 + $29,899 related
- Deferred
- $0 + $23,100 related
- Nontaxable benefits
- $0 + $17,031 related
- Filer's total
- $0 + $781,954 related
-
Michael Deininger MDMICHAEL DEININGER MD
EVP & CHIEF SCIENTIFIC OFFICER
- Total calculated
- $683,113
- From this org
- $32,182
- From related orgs
- $611,478
- Other
- $39,453
- Hours/week
- 3 + 52 related
Schedule J breakdown matched by us
- Base
- $25,305 + $480,803 related
- Bonus
- $5,458 + $103,702 related
- Other
- $1,419 + $26,973 related
- Deferred
- $831 + $15,794 related
- Nontaxable benefits
- $1,141 + $21,687 related
- Filer's total
- $34,154 + $648,959 related
-
Barbara BryantBARBARA BRYANT
EVP & CHIEF MED OFFICER
- Total calculated
- $571,871
- From this org
- $0
- From related orgs
- $546,023
- Other
- $25,848
- Hours/week
- 1 + 54 related
Schedule J breakdown matched by us
- Base
- $0 + $509,725 related
- Bonus
- $0 + $18,210 related
- Other
- $0 + $18,088 related
- Deferred
- $0 + $23,100 related
- Nontaxable benefits
- $0 + $2,748 related
- Filer's total
- $0 + $571,871 related
-
Kelley McCaskillKELLEY MCCASKILL
VP OF PHILANTHROPY
- Total calculated
- $227,859
- From this org
- $191,356
- From related orgs
- $0
- Other
- $36,503
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $168,046
- Bonus
- $22,040
- Other
- $1,270
- Deferred
- $12,278
- Nontaxable benefits
- $24,225
- Filer's total
- $227,859
-
John MabryJOHN MABRY
DIRECTOR TECH TRANSFER
- Total calculated
- $234,963
- From this org
- $181,451
- From related orgs
- $0
- Other
- $53,512
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $174,656
- Bonus
- $6,200
- Other
- $595
- Deferred
- $13,049
- Nontaxable benefits
- $40,463
- Filer's total
- $234,963
-
Alberto G HuertaALBERTO G HUERTA
DIRECTOR FDN DEVELOPMENT
- Total calculated
- $125,339
- From this org
- $108,153
- From related orgs
- $0
- Other
- $17,186
- Hours/week
- 55
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 3
- TOP MANAGEMENT'S COMPENSATION VBRIF DOES NOT DIRECTLY COMPENSATE ITS EMPLOYEES OR OFFICERS; INSTEAD VBRIF RELIES ON ITS RELATED ENTITIES, VERSITI WISCONSIN, INC. AND VERSITI, INC., TO FACILITATE COMPENSATION OF VBRIF EMPLOYEES AND OFFICERS. VERSITI AND ITS AFFILIATED BLOOD CENTERS GREATLY VALUE THE GENEROUS CONTRIBUTIONS OF THE INDIVIDUALS AND ORGANIZATIONS THAT SUPPORT OUR MISSION WITHIN THE COMMUNITY WE SERVE. IN ORDER TO ENSURE PROPER STEWARDSHIP OF OUR CHARITABLE RESOURCES, VERSITI AND ITS AFFILIATES FOLLOW A FORMALIZED PROCESS TO CONFIRM THAT COMPENSATION PROVIDED TO OUR EXECUTIVE LEADERSHIP TEAM IS FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO OTHER EXECUTIVES. THIS PROCESS ALSO HELPS US ENSURE THAT OUR COMPENSATION PROGRAM SUPPORTS THE RETENTION OF EXPERIENCED HIGHLY-QUALIFIED EXECUTIVES WHO ARE COMMITTED TO OUR MISSION. THE EXECUTIVE COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING VBRIF. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE VERSITI BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND TEH OVERALL DUE DILIGENCE PROCESS. VERSITI AND VERSITI WISCONSIN HAVE INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE VERSITI/VERSITI WISCONSIN CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET
- PART I, LINES 5A, 5B, 6A, 6B AND 7:
- NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$8,728,864
RESEARCH
-
$442,848
PROJECT RESEARCH
-
$57,325
ORGAN PROJECTS
-
$13,492
CLINICAL PROJECTS
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · BLOOD · WI
Directly controlled by VERSITI
-
501(C)(3) · SUPPORTING · WI
-
501(C)(3) · BLOOD · IL
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · MI
Directly controlled by VERSITI
-
501(C)(3) · BLOOD · IN
Directly controlled by VERSITI
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 28 October 2024
- IRS schema version
- 2023v5.1
- Source object
- 202413039349301131
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.